PMAs Expedited For Phakic IOLs; Ciba Builds Value For Potential Surgery Sale
This article was originally published in The Gray Sheet
Executive Summary
Ophtec anticipates that its Artisan phakic intraocular lens will go before FDA's Ophthalmic Devices Panel Nov. 6-7, approximately one month after the panel is expected to review Staar Surgical's implantable contact lens (ICL)
You may also be interested in...
AMO Cleared To Market Myopia IOL; Staar Surgical Awaits Site Re-Inspection
Ophtec/Advanced Medical Optics will start U.S. clinical trials next spring for a foldable version of their phakic intraocular lens to correct near-sightedness, building on two years of European study data
AMO Cleared To Market Myopia IOL; Staar Surgical Awaits Site Re-Inspection
Ophtec/Advanced Medical Optics will start U.S. clinical trials next spring for a foldable version of their phakic intraocular lens to correct near-sightedness, building on two years of European study data
Staar, Ophtec Address Panel’s Phakic IOL Endothelial Cell Loss Concerns
FDA Ophthalmic Devices Panel concerns regarding endothelial cell loss associated with phakic intraocular lens implantation will delay review of Ophtec's Artisan phakic IOL by two months, the firm says